HSPB1 and cervical squamous cell carcinoma: In line with these findings, Lomnytska MI et al. [29] assessed the diagnostic value of HSP27 in cervical squamous cell carcinoma (CSCC), enrolling a total of 66 clinical samples, including 8 normal cervix, 13 cervical intraepithelial dysplasia and 45 cases of CSCC with stages from IA1 to III, confirming that reduced HSP27 was markedly associated with worse relapse-free and overall survival.